Stocks and Investing
Stocks and Investing
Wed, June 26, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Andrew Fein Reiterated (WVE) at Strong Buy and Held Target at $15 on, Jun 26th, 2024
Andrew Fein of HC Wainwright & Co., Reiterated "Wave Life Sciences Ltd." (WVE) at Strong Buy and Held Target at $15 on, Jun 26th, 2024.
Andrew has made no other calls on WVE in the last 4 months.
There are 4 other peers that have a rating on WVE. Out of the 4 peers that are also analyzing WVE, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $5 on, Thursday, March 7th, 2024
These are the ratings of the 3 analyists that currently disagree with Andrew
- Salim Syed of "Mizuho" Reiterated at Buy and Held Target at $19 on, Tuesday, June 25th, 2024
- Tiago Fauth of "Wells Fargo" Initiated at Buy and Held Target at $11 on, Wednesday, May 15th, 2024
- Joon Lee of "Truist Securities" Reiterated at Strong Buy and Held Target at $17 on, Monday, April 1st, 2024
Contributing Sources